Chlorin E6–based Photodynamic Therapy (PDT) is a minimally invasive approach to advanced wound care that uses light-activated photosensitization to target microorganisms within the wound environment. It offers a potential antibiotic-sparing option for the management of chronic and diabetic wounds, particularly where bacterial burden and antimicrobial resistance are key concerns.

Clinical studies and reported cases have demonstrated reductions in bacterial load and encouraging wound-healing outcomes following Chlorin E6–based PDT. Used alongside established wound-care protocols, this innovative therapy may support infection control and promote an environment conducive to wound healing.